- Companies
- Mindstrong Health
Mindstrong Health Funding, Investors & Competitors
Mindstrong Health has raised $160M across 4 funding rounds, most recently a $100M Series C in May 2020.
Last Mindstrong Health funding round
$100M
Series C · May 2020
Cumulative funding Mindstrong Health raised
$160M
across 4 funding rounds
Key investors in Mindstrong Health
ARCH Venture Partners
Foresite Capital
Optum Ventures
General Catalyst
Bezos Expeditions
8VC
Human Capital
Decheng Capital
About Mindstrong Health
Mindstrong Health was a digital mental health platform using smartphone data for passive monitoring and personalized interventions. The service provided virtual therapy and coaching for conditions including depression and schizophrenia. California-headquartered, it raised significant funding before winding down operations in 2022.
Founded
2014
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Subscription
Mindstrong Health Funding History
Mindstrong Health has raised a total of $160M across 4 funding rounds.
Mindstrong Health's first fundraising round was a $14M Series A in June 2017. The most recent completed round was a $100M Series C in May 2020.
Mindstrong Health funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| May 2020 | Series C | General Catalyst; 8VC; Foresite Capital; Human Capital; Bezos Expeditions; What If Ventures; Optum Ventures; ARCH Venture Partners | $100M | Mindstrong Health is a digital mental health company offering virtual care models and digital symptom measurement for people with serious mental illness (SMI), such as bipolar disorder or major depression. Through its smartphone app, it provides text-based cognitive behavioral therapy, telehealth services with psychiatrists, coping strategies, psychoeducation, crisis management, and remote patient monitoring based on smartphone usage patterns like typing and scrolling. The in-house clinical team of therapists, psychiatrists, and care coordinators delivers unlimited services at no cost to members via value-based partnerships with national private and public insurance payers. On May 21, 2020, Mindstrong announced a $100 million Series C funding round with participation from investors including General Catalyst, ARCH Venture Partners, Foresite Capital, 8VC, Optum Ventures, What If Ventures, Bezos Expeditions, and others. The capital is intended to scale its virtual mental healthcare and digital symptom measurement offerings amid rising demand due to the COVID-19 pandemic, which exacerbated mental health challenges. Previously, the company raised $31 million in Series A funding and over $150 million total since inception in 2014. Founded on research by Paul Dagum, now chief scientific officer, Mindstrong transitioned from R&D to commercial availability, appointing former Uber product head Daniel Graf as CEO in November 2019 to drive consumer-focused growth. Investors highlighted its clinically demonstrated cost-effective health assurance for underserved SMI populations, where over 60% of U.S. counties lack practicing psychiatrists. The platform aims to prevent expensive episodes and save health systems billions while improving access and outcomes. This round occurred during a surge in telehealth funding, with $930 million raised in Q1 2020, reflecting broader interest in digital health solutions. Mindstrong differentiates by targeting severe cases rather than general wellness, leveraging biomarker technology from smartphone behaviors validated in studies like one with a ketamine clinic. |
| Dec 2018 | Series B | General Catalyst (lead) | $31M | - |
| Jun 2018 | Series B | Bezos Expeditions (lead); Decheng Capital; Foresite Capital; Optum Ventures; ARCH Venture Partners | $15M | Mindstrong Health raised $15 million in a Series B funding round in June 2018 led by Bezos Expeditions, with participation from ARCH Venture Partners, Decheng Capital, Foresite Capital, and Optum Ventures. The company, founded in 2014, develops digital biomarkers and virtual care models to measure brain function from smartphone data for mental health conditions like schizophrenia and treatment-resistant depression. This round followed a $14 million raise in June 2017. Mindstrong Health is based in Mountain View, California, and focuses on neuroscience precision therapy. |
| Jun 2017 | Series A | ARCH Venture Partners (lead); Foresite Capital (lead); Berggruen Holdings; One Mind Brain Health Impact Fund; Optum Ventures | $14M | Mindstrong Health raised $14 million in Series A funding on June 15, 2017, led by Foresite Capital and ARCH Venture Partners, with participation from Optum Ventures, Berggruen Holdings, and One Mind Brain Health Impact Fund. The company, founded in 2014, develops AI and mobile technology to transform diagnosis and treatment of neuropsychiatric disorders by measuring brain function through smartphone interaction patterns. The funding supports building technology and clinical operations teams for large-scale research and development. Mindstrong's platform provides real-time digital biomarkers of mood and cognition, including processing speed, attention, memory, and executive function, based on four years of clinical research. The founding team includes expertise from the former Director of the National Institute of Mental Health. |
Who has invested in Mindstrong Health?
11 investors have backed Mindstrong Health across its funding rounds, including ARCH Venture Partners, Foresite Capital, Optum Ventures, General Catalyst, Bezos Expeditions and 8VC.
Lead investors include General Catalyst, Bezos Expeditions, ARCH Venture Partners and Foresite Capital.
Mindstrong Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Jun 2017 | ||
| 3 | Participant | Jun 2017 | ||
| 3 | Lead | Jun 2017 | ||
| 2 | Lead | Dec 2018 | ||
| 2 | Lead | Jun 2018 | ||
| 1 | Participant | May 2020 | ||
| 1 | Participant | Jun 2017 | ||
| 1 | Participant | Jun 2018 | ||
| 1 | Participant | May 2020 | ||
This data is available for Pro users. Sign up to see all 11 Mindstrong Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialMindstrong Health Competitors
Mindstrong Health competitors include listed companies like Hims and Teladoc, and private ones like Cerebral, Grow Therapy, Headway and Nourish.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $2.3B | $178M | $6.5B | 2.4x | ||
| Private | - | - | $4.8B | - | ||
| Private | $1B | - | $3B | - | ||
| Private | - | - | $2.3B | - | ||
| Private | $160M | - | $1.8B | 10.9x | ||
| Publicly listed | $2.5B | $124M | $1.1B | 0.6x |
Mindstrong Health Public Comps
Mindstrong Health is still privately-owned, but its public comps include Humana Inc., Max Healthcare Institute, Oscar Health, Hims, Doximity, ACADIA Pharmaceuticals, Compass Pathways, Ping An Healthcare, JMDC and GoodRx.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $130B | $3B | 0.4x | 0.3x | 17.8x | 16.6x | |||
| $858M | $232M | 12.6x | 10.2x | 46.5x | 36.8x | |||
| $12B | ($391M) | 0.5x | 0.4x | (15.9x) | 12.8x | |||
| $2.3B | $178M | 3.1x | 2.4x | 40.4x | 23.9x | |||
| $645M | $229M | 6.3x | 6.2x | 17.7x | 11.9x | |||
| $1.1B | $119M | 3.6x | 3.2x | 32.3x | 33.6x | |||
| - | ($293M) | - | - | (5.8x) | (8.4x) | |||
| $815M | $52M | 0.9x | 0.9x | 13.4x | 16.9x | |||
This data is available for Pro users. Sign up to see all Mindstrong Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Mindstrong Health
| When was Mindstrong Health founded? | Mindstrong Health was founded in 2014. |
| Where is Mindstrong Health headquartered? | Mindstrong Health is headquartered in San Francisco, CA, United States. |
| Is Mindstrong Health publicly listed? | No, Mindstrong Health is a private, VC-backed company. |
| How much funding has Mindstrong Health raised? | Mindstrong Health has raised $160M across 4 funding rounds. |
| What was Mindstrong Health's last funding round? | Mindstrong Health's last funding round was a $100M Series C in May 2020. |
| Who are Mindstrong Health's investors? | Mindstrong Health's investors include Foresite Capital, Optum Ventures, ARCH Venture Partners, General Catalyst, Bezos Expeditions, 8VC, Berggruen Holdings, Decheng Capital, Human Capital, One Mind Brain Health Impact Fund and 1 other. |
| Which companies are comparable to Mindstrong Health? | Companies comparable to Mindstrong Health include Hims, Cerebral, Grow Therapy, Headway, Nourish and Teladoc. |
See companies similar to Mindstrong Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




